Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Bisphosphonates and increased AF rates: FDA says no clear link

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      FDA.Update of Safety Review Follow-up to the October 1, 2007 Early Communication about the Ongoing Safety Review of Bisphosphonates. Media Release: 12 Nov 2008. Available from: URL: http://www.fda.gov

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Bisphosphonates and increased AF rates: FDA says no clear link. React. Wkly. 1229, 3 (2008). https://doi.org/10.2165/00128415-200812290-00006

    Download citation

    Keywords

    • Public Health
    • Clinical Trial
    • Atrial Fibrillation
    • Epidemiological Study
    • Bisphosphonate